2013

“EVENTS” 3D text surrounded by calendar dates. Part of a series.

  • Milagen files Mexican Patent Application N° MX/a/2013/013365 entitled “High-throughput Integrated system for detection of gynecological diseases”
  • Milagen establishes a strategic partnership with Servacare, a Mexico-based clinical laboratory for the commercialization of its cervical disease related products
  • Milagen files US Patent Applications on biomarkers, i.e. “A biological marker for early cancer detection and methods for cancer detection (BF819)” 13/931,432
  • Milagen is pleased to receive from the Mexico Regulatory Agency COFEPRIS the approval for the commercialization in Mexico to the public and private diagnostic sector, of the following Milagen IVD products of Class I, with validity until 2018:
  • MUC-6 Registration # 3137R2013SSA
  • CK17 Registration # 1088R2013SSA